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Abstract
Introduction: Although membranoproliferative glomerulonephritis has been reported to occur in
association with non-Hodgkin’s lymphoma, information concerning the long term effects of treatment
of non-Hodgkin’s lymphoma on the associated membranoproliferative glomerulonephritis is limited.
Case presentation: The current report describes a patient who presented with the abrupt onset of
hypertension, mixed nephritic/nephrotic syndrome and acute renal failure. Kidney biopsy was
consistent with membranoproliferative glomerulonephritis, type 1. Bone marrow biopsy performed
in the evaluation of periaortic lymphadenopathy, hepatosplenomegaly, and thrombocytopenia
confirmed the diagnosis of low grade B-cell non-Hodgkin’s lymphoma. The patient’s renal function
improved and proteinuria resolved after initial treatment of non-Hodgkin’s lymphoma with
chemotherapy. During eleven years of follow up, membranoproliferative glomerulonephritis has
remained in remission, as confirmed by repeatedly negative urinalyses, normal blood pressure and
absence of clinical signs and symptoms suggestive of nephritic/nephrotic syndrome.
Conclusion: Membranoproliferative glomerulonephritis has been known to be associated with both
chronic lymphocytic leukemia and non-Hodgkin’s lymphoma, particularly with B cell lymphocytic type
non-Hodgkin’s lymphoma. There is limited information available concerning the effects of treatment
of non-Hodgkin’s lymphoma on the progression of non-Hodgkin’sl y m p h o m aa s s o c i a t e d
membranoproliferative glomerulonephritis. In the few reported cases we found, long term follow
up after initial resolution of the membranoproliferative glomerulonephritis was lacking. This report
presented a rare case of non-Hodgkin’s lymphoma associated membranoproliferative glomerulone-
phritis, that continued to be in remission during eleven years of follow up after initial chemotherapy
treatment of lymphoma.
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Glomerulonephritis is a rare complication of hemato-
logical malignancies [1-3]. Chronic lymphocytic leukemia
(CLL) and Non-Hodgkin’s lymphoma (NHL) have been
the most common hematologic malignancies associated
with glomerular diseases [3]. Membranoproliferative
glomerulonephritis (MPGN) has been the most com-
monly reported glomerular disease associated with CLL
and has also been associated with Non-Hodgkin’s
lymphoma [1,3,4]. Although treatment of CLL with
systemic chemotherapy has been previously associated
with resolution of MPGN [2], information concerning the
effects of treatment of NHL on the clinically associated
MPGN, however, is limited and long term follow up is
lacking in previously reported cases [3].
This report describes a patient who was diagnosed with
MPGN and NHL simultaneously. MPGN and NHL
resolved after treatment with chemotherapy. MPGN
continued to be in remission during 11 years of follow
up after treatment of NHL with chemotherapy.
Case presentation
A 64 year old previously healthy white male construction
worker presented with a four-week history of progressive
shortness of breath, bilateral lower limb swelling,
increased abdominal girth and a thirty pound weight
gain. He was found to have new onset hypertension and
an abnormal urinalysis.
On physical examination temperature was 98.6, pulse
was 64 beat per minute and blood pressure was
208/104 mmHg. Fundoscopic exam was normal. Jugular
veins were distended. Heart examination showed a
displaced apical impulse. Breath sounds were decreased
on the right side of the chest. The abdomen was
remarkable for marked splenomegaly and shifting dull-
ness. There was marked pretibial edema. No peripheral
lymphadenopathy was detected.
Initial laboratory evaluation showed a white blood cell
count of 7.2 ×10
9/L, hematocrit 34%, and platelet count
99 × 10
9/L. The serum creatinine was 2.9 mg/dl, and blood
urea nitrogen was 37 mg/dl. Serum electrolytes were
(in meq/l) sodium 143, potassium 4.3, chloride 112, and
bicarbonate 22. Hepatic transaminases, alkaline phos-
phatase,andprothrombintimewerenormal.Totalprotein
was 4.8 g/dl and albumin 2.6 g/dl. Urinalysis showed
3
+ blood, 3
+ protein with abundant granular casts and
RBCS but no cellular casts. 24 hour urinary protein
excretion was 28 g. Serum immunofixation electrophoresis,
SPEP and UPEP were negative for monoclonal bands.
Serum complement (C3) was 72.3 mg/dl (83-193) and C4
was 22.8 mg/dl (12-36). Rheumatoid factor was 299 IU
(0-29). Tests for hepatitis B surface antigen, hepatitis C
antibody, RPR, human immunodeficiency virus antibodies,
streptozyme, and antinuclear antibodies were negative.
Chest radiographic study showed a right pleural effusion
and a normal sized heart. Computerized tomography of
the abdomen showed hepatosplenomegaly and periaortic
lymphadenopathy. Doppler ultrasonography of the
kidneys was normal.
Pathologic findings
A percutaneous renal biopsy was performed. Light
microscopy showed increased cellularity in all glomeruli
and accentuation of lobular architecture. Silver staining
showed double contours within the capillary loops.
Epithelial crescents were not present. Immunofluorescence
studies showed granular staining in a lobular pattern for
IgG, IgM, Kappa, and lambda. Electron microscopy
showed subendothelial and mesangial fine electron
dense deposits (Figure 1). These histologic changes were
consistent with MPGN, type 1. There was no evidence of
lymphomatous infiltration and there was no histological
evidence of cyroglobulin deposition or amyloidosis.
Figure 1. Electron-microscopy: Subendothelial electron-
dense deposits were seen along the basement membrane.
Mesangial electron-dense deposits were also detected. These
histologic changes were consistent with MPGN, type 1.
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cellular bone marrow (80%) with extensive infiltration of
small B cell lymphoctyes. The B cells were positive for the
B cell marker CD20 and negative for T cell markers CD5
and CD3. The final diagnosis was low grade B cell NHL.
Long-term follow up
After initial treatment with six cycles of cyclophospha-
mide, vincristine, and prednisone. The patient improved
symptomatically and his blood pressure normalized.
Serum creatinine, which initially peaked at 7.1 mg/dl,
decreased dramatically to a baseline level of 1.4 - 1.7 mg/
dl. Urine protein excretion decreased to <300 mg/24hr.
Microscopic hematuria resolved. Serum albumin
increased to 3.5-4.0 g/dl with resolution of the protei-
nuria. The anemia and thrombocytopenia resolved.
Repeated computed tomography of the abdomen at
intervals of six and 12 months showed improvement in
splenomegaly and periaortic lymphadenopathy. A repeat
bone marrow biopsy showed no evidence for NHL.
During long term follow up, the patient has had two
relapses of NHL confirmed by bone marrow biopsies. The
first relapse was treated with six cycles of fludarabine and
mitoxantrone and the second with rituximab. Subsequent
bone marrow biopsy showed no evidence for lymphoma,
and computed tomography of the abdomen and pelvis
showed resolution of lymphadenopathy with interval
improvement in splenomegaly. In each relapse there was
a transient increase in the serum creatinine concentration,
up to 2 mg/dl, that was attributed to factors other than
MPGN. Urinalysis remained normal. The patient con-
tinues to be in complete remission with respect to his
MPGN and NHL, approximately 11 years following the
initial diagnosis.
Discussion
The current report describes a patient with previously
normal kidney function who developed rapidly progres-
sive membranoproliferative glomerulonephritis (MPGN,
type I) in association with low grade non-Hodgkin’s
lymphoma. None of the more commonly associated
clinical entities with MPGN type I were identified.
Subsequent chemotherapy led to remission of NHL and
to complete and persistent resolution of glomerulo-
nephritis during eleven years of follow up.
Glomerular diseases have been known to be associated
with both chronic lymphocytic leukemia and non-
Hodgkin’s lymphoma, particularly with B cell lymphocytic
type NHL [1,2,4,5]. Membranoproliferative glomerulone-
phritis has been the most commonly reported histological
diagnosis. Minimal change disease, focal segmental
glomerulosclerosis, membranousglomerulopathy,mesan-
gial proliferative glomerulonephritis, IgA nephropathy,
and monoclonal immunoglobulin deposit diseases have
also beenreported. Glomerular involvement haspreceded,
coexisted with or even followed the diagnosis of
lymphoma by several years.
The pathogenesis of non-Hodgkin’s lymphoma-associated
glomerulonephritis is poorly understood [5-7]. A
current concept of the pathogenesis of paraneoplastic
glomerulonephritisfocusesonimmunecomplexescontain-
ing tumor antigens, which are deposited in the glomeruli
[6,7]. Autoimmune mechanisms and T- lymphocyte
dysfunction have also been postulated to play a role
in pathogenesis [5-7]. Glomerulonephritis may also be
related to the production of cryoglobulins and/or
immunoglobulin synthesis (paraprotein production) by
the secretory B cell clone [8]. Chronic hepatitis C virus
infection is currently the most common cause of
secondary MPGN and is often associated with cryo-
globulinemia. Although HCV serology was negative in this
patient, any condition associated with persistent immu-
nological stimulation can result in secondary cryoglobu-
linemia. Cryoglobulins were not directly measured in our
patient; rheumatoid factor activity, however, was detected
at the time of the diagnosis of MPGN and was
undetectable after the resolution of glomerulonephritis
such that cryoglobulinemia cannot be excluded as a
pathogenic mechanism in this patient. Para proteins
were not detected in our patient, and there was no electron
microscopic evidence of fibrillary glomerulonephritis,
immunotactoid glomerulopathy, or lymphomatous infil-
tration of the kidney [9,10].
There is limited information available concerning the
effects of treatment of NHL on the progression of NHL
associated MPGN. Moulin, et al. reported one patient
with NHL who developed complete remission of MPGN
after treatment with chlorambucil and a second patient
who showed significantly improved renal function after
treatment with MOPP (nitrogen mustard, vincristine,
procarbazine, prednisone). Stokes, et al. described a
patient with low-grade B-cell lymphoma and MPGN,
who responded by improvement in renal function and
diminution of proteinuria after treatment with oral
prednisone.
MPGN in our patient continues to be in clinical remission
with normal kidney function and normal urinalysis
11 years after the initial treatment of NHL despite two
relapses of NHL that were effectively treated with
additional chemotherapy. In each relapse of NHL there
was a transient increase in serum creatinine concentration
that was attributed to factors other than MPGN, as
suggested by repeatedly normal urinalyses, normal blood
pressure and the absence of clinical signs and symptoms
associated with nephritic/nephrotic syndrome.
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The findings of normal renal function prior to the
development of NHL in our patient, the development of
MPGN temporally associated with the onset of NHL, the
absence of other known causes of secondary MPGN, and
remission of MPGN following NHL treatment strongly
support a pathogenetic mechanism involving cryo-
globulins or tumor antigens in the development of
MPGN, type I. Early treatment of NHL with chemotherapy
can be associated with long term remission of the
associated MPGN as described in this report which was
rarely reported in literature. This case underlines the
importance of aggressive treatment of malignancy in
patients with glomerulonephritis and of glomerulone-
phritis in patients with malignancy.
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